The first announcement that ONCARLYTICS COMBO Trial was opened on 11/3/24.
https://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvSTYM4Aa5yBOZqfpske92GA==The First Patient In was announced today 109 days later? If my maths is correct that is..
The Bile Duct Expansion Trial opened on 15/4/24. Some 35 days after the Oncarlytics Combo was announced. Or 74 days ago.
Today posters are implying and claiming that the Bile Duct Expansion Triak has problems. How do they make this garbage up.
Soon , probably within 35 days we will get a FPI a for the Bile Duct Trial.
As always don’t listen to the negative posters who make up all sorts of rubbish to post. Go to the company announcements, videos and presentations for your information. Get the facts . Don’t rely on the BS many people spread on here.
In fact the FPI in on Oncarlytics Monotherapy was announced on 26/10/23. So being open label LC has been privy to information about this arm of the trial for 7 months.
https://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvSTYM4Qe9wBSZqfpske92GA==We have about 5 months to wait to find out for certain how well the biggest innovation in cancer treatments is going . At that time you will get early data on 3-6 patients in combo BLINCYTO therapy. But you will also get 12 months worth of Monotherapy data.
As investors the biggest question we are waiting on is whether ONCARLYTICS marks the solid tumors with a CD19 flag.
We might even get that news well before the Blicynto news. It’s likely that this data will be presented at a prestigious conference before long !
So do your research and don’t be swayed by irrational pessimism posted here by immature investors who don’t understand drug development. As Leslie said “ it’s not for bedwetters!”
